Siqi Han
305 Zhongshan East Road
Nanjing, 210002, China
Nanjing, 210002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
A predictive 14-gene signature and FLI1 inhibition overcome tumor-infiltrating lymphocyte dysfunction in triple-negative breast cancer.
Journal: Biochemical and biophysical research communications
Published: March 12, 2026
Expanding the applications of immune checkpoint inhibitors in advanced lung cancer beyond disease progression.
Journal: Frontiers in immunology
Published: July 25, 2023
Retraction Note: The lincRNA-ROR/miR-145 axis promotes invasion and metastasis in hepatocellular carcinoma via induction of epithelial-mesenchymal transition by targeting ZEB2.
Journal: Scientific reports
Published: March 29, 2023
Retraction Note to: MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial-mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma.
Journal: Molecular cancer
Published: August 24, 2022
Biotinylated curcumin as a novel chemosensitizer enhances naphthalimide-induced autophagic cell death in breast cancer cells.
Journal: European journal of medicinal chemistry
Published: September 13, 2021
Delivery of Anti-miRNA-221 for Colorectal Carcinoma Therapy Using Modified Cord Blood Mesenchymal Stem Cells-Derived Exosomes.
Journal: Frontiers in molecular biosciences
Published: July 17, 2021
IL-7 and CCR2b Co-Expression-Mediated Enhanced CAR-T Survival and Infiltration in Solid Tumors.
Journal: Frontiers in oncology
Published: July 01, 2021
PHF5A promotes colorectal cancerprogression by alternative splicing of TEAD2.
Journal: Molecular therapy. Nucleic acids
Published: April 14, 2021
Clinical Effects of Stereotactic Body Radiation Therapy Targeting the Primary Tumor of Liver-Only Oligometastatic Pancreatic Cancer.
Journal: Frontiers in oncology
Published: January 28, 2021
Hydrogen sulfide triggered molecular agent for imaging and cancer therapy.
Journal: Chemical communications (Cambridge, England)
Published: January 26, 2021
TriBAFF-CAR-T cells eliminate B-cell malignancies with BAFFR-expression and CD19 antigen loss.
Journal: Cancer cell international
Published: January 20, 2021
CRISPR screen in cancer: status quo and future perspectives.
Journal: American journal of cancer research
Published: October 20, 2020
Last Updated: 09/26/2026